Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ORIC-101 |
Trade Name | |
Synonyms | ORIC101|ORIC 101 |
Drug Descriptions |
ORIC-101 is an antagonist of the glucocorticoid receptor (GR), which has potential antitumor activity (PMID: 30091920). |
DrugClasses | GR Antagonist 2 |
CAS Registry Number | NA |
NCIT ID | C162509 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Gemcitabine + ORIC-101 | Carboplatin Gemcitabine ORIC-101 | 0 | 0 |
Enzalutamide + ORIC-101 | Enzalutamide ORIC-101 | 0 | 1 |
Nab-paclitaxel + ORIC-101 | Nab-paclitaxel ORIC-101 | 0 | 1 |
ORIC-101 | ORIC-101 | 0 | 0 |